LearnGlossaryMarketStocksSuperinvestorsSign in

CVRX

CVRx, Inc.

Healthcare · $68M market cap

Verdict

We can't put a fair value on CVRX right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-32.7% a year✗
Sales growth53.1% a year✓
Free cash flow growth—?
Return on invested capital-48.2%✗

Follow CVRX

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds CVRX right now. In Q1 2026, 1 sold out. Who we track

Moves in Q1 2026

Sold out: Mairs & Power Funds

About CVRx, Inc.

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works